- Home
- EQX vs ALKS Comparison
EQX vs ALKS Comparison
Compare EQX & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQX
- ALKS
- Stock Information
- Founded
- EQX 2007
- ALKS 1987
- Country
- EQX Canada
- ALKS Ireland
- Employees
- EQX N/A
- ALKS N/A
- Industry
- EQX Precious Metals
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- EQX Basic Materials
- ALKS Health Care
- Exchange
- EQX Nasdaq
- ALKS Nasdaq
- Market Cap
- EQX 6.1B
- ALKS 5.1B
- IPO Year
- EQX N/A
- ALKS 1991
- Fundamental
- Price
- EQX $8.24
- ALKS $28.97
- Analyst Decision
- EQX
- ALKS Strong Buy
- Analyst Count
- EQX 0
- ALKS 13
- Target Price
- EQX N/A
- ALKS $40.38
- AVG Volume (30 Days)
- EQX 13.6M
- ALKS 1.3M
- Earning Date
- EQX 08-13-2025
- ALKS 10-23-2025
- Dividend Yield
- EQX N/A
- ALKS N/A
- EPS Growth
- EQX N/A
- ALKS 21.99
- EPS
- EQX N/A
- ALKS 2.08
- Revenue
- EQX $1,905,732,000.00
- ALKS $1,505,296,000.00
- Revenue This Year
- EQX $59.63
- ALKS N/A
- Revenue Next Year
- EQX $44.19
- ALKS $1.66
- P/E Ratio
- EQX N/A
- ALKS $13.96
- Revenue Growth
- EQX 74.31
- ALKS N/A
- 52 Week Low
- EQX $4.95
- ALKS $25.56
- 52 Week High
- EQX $8.28
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- EQX 74.88
- ALKS 55.04
- Support Level
- EQX $8.07
- ALKS $28.64
- Resistance Level
- EQX $8.28
- ALKS $29.39
- Average True Range (ATR)
- EQX 0.29
- ALKS 0.68
- MACD
- EQX 0.08
- ALKS 0.17
- Stochastic Oscillator
- EQX 97.01
- ALKS 71.55
About EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.